Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 52 | 2 |

Tytuł artykułu

Protective effect of pCI-neo vector-mediated DNA vaccine against Chlamydophila abortus in mice


Warianty tytułu

Języki publikacji



In the presented study, omp-1 gene coding main outer membrane protein of Chlamydophila abortus was cloned into pCI-neo and pcDNA3.1 as delivery vehicles for DNA vaccination. Thirty-six BALB/c mice were randomly assigned to three groups and inoculated intramuscularly with: 1) 100 µg of pCI-neo, 2) 100 µg of pCI-neo::MOMP, and 3) 100 µg of pcDNA3.1::MOMP. All animals were vaccinated three times at 14 d intervals. The results showed that mice given pCI-neo::MOMP developed a higher IgG antibody level, high T lymphocytes proliferations, and high titres of IFN-γ and IL-2, than mice given pcDNA3.1::MOMP, which induced moderate antibody levels, less T lymphocyte proliferations and lower cytokine levels. No significant difference of TNF-α was observed in above groups. Additionally, IgG2a and Ig2b were the predominant isotypes on day 44, suggesting a high level of Th1 stimulation. Mice given the pCI-neo::MOMP also elicited a higher chlamydial clearance and a better protection than mice with pcDNA3.1::MOMP did. Immunisation with pCI-neo::MOMP vaccine may provide novel ways for active immunisation strategy against Chlamydophila abortus.








Opis fizyczny



  • Huazhong Agricultural University, Wuhan 430070, China


  • 1. Babiuk L. A., Pontarollo R., Babiuk S., Loehr B., van Drunen, Littel-van den Hurk S.: Induction of immune responses by DNA vaccines in large animals. Vaccine 2003, 21, 649-658.
  • 2. Barry M.E., Pinto-Gonzalez D., Orson F.M., McKenzie G.J., Petry G.R., Barry M.A.: Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther 1999, 10, 2461-2480.
  • 3. Boutorine A.S., Kostina E.V.: Reversible covalent attachment of cholesterol to ligodeoxyribonucleotides for studies of the mechanisms of their penetration into eucaryotic cells. Biochimie 1993, 75, 35-41.
  • 4. Bothwell A.L.M.: Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell 1981, 24, 625.
  • 5. Brown J., Entrican G.: Interferon-gamma mediates long-term persistent Chlamydial psittaci infection in vitro. J Comp Pathol 1996, 115, 373-383.
  • 6. Buxton D.: Potential danger to pregnant women of Chlamydia psittaci from sheep. Vet Rec 1986, 118, 510-511.
  • 7. Buzoni-Gatel D., Bernard F., Andersen A., Rodolakis A.: Protective effect of polyclonal and monoclonal antibodies against abortion in mice infected by Chlamydia psittaci. Vaccine 1990, 8, 342-346.
  • 8. Caldwell H.D., Kromhout J., Schachter J.: Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981, 31, 1161-1176.
  • 9. De Sa C., Souriau A., Bernard F., Salinas J., Rodolakis A.: An oligomer of the major outer membrane protein of Chlamydia psittaci is recognized by monoclonal antibodies, which protect mice from abortion. Infect Immun 1995, 63, 4912-4916.
  • 10. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A.: DNA vaccines. Annu Rev Immunol 1997, 15, 617-648.
  • 11. Gluzman Y.: SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981, 23, 175.
  • 12. Gurunathan S., Klinman D.M., Seder R.A.: DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000, 18, 927-974.
  • 13. He C., Li S., Yang L., He G.M., Liu W., Yao B.: Induction of a protective immune response against Chlamydophila psittaci SPF chickens following vaccination with omp-1 and CpG oligonucleotides as an adjuvant. Bull Vet Inst in Pulawy 2007, 51, 351-356.
  • 14. Hechard C., Grepinet O., Rodolakis A.: Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice. J Med Microbiol 2003, 52, 35-40.
  • 15. Huang M.T.F., Gorman C.M.: Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA. Nuci Acids Res 1990, 18, 937-947.
  • 16. Kozak M.: Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol Cell Biol 1989, 9, 5134-5142.
  • 17. Longbottom D., Livingstone M.: Vaccination against chlamydial infections of man and animals. Vet J 2006, 171, 263-275.
  • 18. March J.B., Clark J.R., Jepson C.D.: Genetic immunization against hepatitis B using whole bacteriophage λ particles. Vaccine 2004, 22, 1666-1671.
  • 19. Penttila T., Vuola J.M., Puurula V., Anttila M., Sarvas M., Rautonen N., Makela P.H., Puolakkainen M.: Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine 2000, 19, 1256-1265.
  • 20. Strugnell R.A., Drew D., Mercieca J., DiNatale S., Firez N., Dunston S.J., Simmons C.P., Vadolas J.: DNA vaccines for bacterial infections. Immunol Cell Biol 1997, 75, 364-369.
  • 21. Tan T.W., Herring A.J., Anderson I.E., Jones G.: Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun 1990, 58, 3101-3108.
  • 22. Vanrompay D., Cox E., Vandenbussche F., Volckaert G., Goddeeris B.: Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 1999, 17, 2628-2635.
  • 23. Verminnen K., Van Loock M., Cox E., Goddeeris B.M., Vanrompay D.: Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1α,25-dihydroxyvitamin D3. Vaccine 2005, 23, 4509-4516.
  • 24. Yang Q., He C., Lei M., Li Y.: Cloning and prokaryotic expression of omp-1 gene of swine Chlamydophila abortus CP12. J China Agricult Univers 2005, 10, 56-59.
  • 25. Zhang D.J., Yang X., Berry J., Shen C., McClarty G., Brunham R.C.: DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 1997, 176, 1035-1040.
  • 26. Zhang D.J., Yang X., Shen C., Lu H., Murdin A., Brunham R.C.: Priming with Chlamydia trachomatis major outer membrane protein DNA followed by MOMP ISCOM boosting enhanced protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect Immun 2000, 68, 3074-3078.

Typ dokumentu



Identyfikator YADDA

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.